Lupin receives USFDA approval for generic Lidex Ointment

01 Aug 2017 Evaluate

Lupin has received final approval for its Fluocinonide Topical Ointment USP, 0.05% from the United States Food and Drug Administration (USFDA) to market a generic version of County Line Pharmaceuticals, LLC’s Lidex Ointment, 0.05%. Lidex Ointment had US sales of $40.3 million, as per IMS MAT March 2017.

Lupin’s Fluocinonide Topical Ointment USP, 0.05% is AB rated generic equivalent of County Line Pharmaceuticals, LLC’s Lidex Ointment, 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2124.65 -26.40 (-1.23%)
01-Feb-2026 14:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.80
Dr. Reddys Lab 1199.65
Cipla 1325.70
Zydus Lifesciences 887.35
Lupin 2124.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×